- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 20.03. | Boku - Making the complex simple for global merchants | 305 | Boku's strategy to widen its offering within the local payment method (LPM) market accelerated FY23 revenue growth to 30%, with 15% growth from the core direct carrier billing (DCB) business and supplemented... ► Artikel lesen | ||
| 20.03. | Tinexta - Strongest year since FY18 | 147 | Tinexta enjoyed its strongest year for underlying profit growth in FY23 since FY18 which, given the recent challenging macro environment, is testimony to the changes in its business portfolio. Management... ► Artikel lesen | ||
| 20.03. | IRLAB Therapeutics - Mesdopetam's potential highlighted in PD-psychosis | 196 | The recent scientific paper in Neurotherapeutics discusses the encouraging preclinical studies focused on the characterisation of the neurophysiological brain state in Parkinson's disease psychosis... ► Artikel lesen | ||
| 20.03. | Newron Pharmaceuticals - Evenamide set for a pivotal year | 481 | Newron Pharmaceuticals has reported results for FY23, an active period for its lead asset, evenamide, being developed for treatment-resistant schizophrenia (TRS) and poorly managed schizophrenia (non-TRS).... ► Artikel lesen | ||
| 20.03. | The Biotech Growth Trust - Onwards and upwards for performance recovery | 206 | The Biotech Growth Trust's (BIOG's) two co-managers, Geoff Hsu and Josh Golomb, at global healthcare specialist OrbiMed, believe that now could be an opportune time to consider the biotech sector as... ► Artikel lesen | ||
| 19.03. | OPAP - A good end to FY23 | 432 | OPAP enjoyed good growth from its land-based activities, as well as through the continued expansion of its online activities in FY23, and the company surpassed its own profit expectations. Ongoing enhancements... ► Artikel lesen | ||
| 19.03. | Team Internet Group - Growth and returns, acquisition bolsters outlook | 214 | Team Internet's FY23 results exceeded our forecasts and consensus on revenue and EBITDA. Online Marketing was driven by increased consumer engagement, reflecting investment in delivering more targeted... ► Artikel lesen | ||
| 19.03. | OSE Immunotherapeutics - One step closer to key data readouts | 215 | OSE Immunotherapeutics has announced the completion of patient enrolment in its Phase II CoTikiS trial, marking another step in the clinical development of its novel anti-IL-7R antibody, OSE-127/Lusvertikimab... ► Artikel lesen | ||
| 18.03. | Wheaton Precious Metals - Celebrating the Ides of March | 299 | Wheaton's (WPM's) Q4/FY23 results were released after the market close on 14 March, within the context of known metals sales and almost known production. Even so, net earnings were US$2.9m (or 1.8%)... ► Artikel lesen | ||
| 18.03. | Borussia Dortmund - Progressing nicely | 310 | Borussia Dortmund's first team was successful in progressing through to quarter finals of the Champions League, which naturally leads to an upgrade in profit guidance for the year, as reaching the 'round... ► Artikel lesen | ||
| 18.03. | SIGA Technologies - Onwards and upwards with strong FY23 | 246 | SIGA Technologies has delivered its best top-line performance in the last five years, supported by a late surge in TPOXX deliveries across both domestic and international markets. FY23 product revenues... ► Artikel lesen | ||
| 18.03. | EML Payments - Sale of Sentenial agreed | 190 | EML Payments has agreed to sell Sentenial to GoCardless for an enterprise value of €32.75m/A$54.1m. As Sentenial is currently loss-making, the disposal will be earnings and cashflow accretive to EML... ► Artikel lesen | ||
| 15.03. | Newron Pharmaceuticals - Operational flexibility with new/updated financing | 281 | Newron Pharmaceuticals has announced new arrangements that offer the company improved operational flexibility. We estimate a pro forma gross cash balance of €17.5m (estimated year-end gross cash of... ► Artikel lesen | ||
| 15.03. | musicMagpie - Focus on profits and cash in FY23 | 165 | musicMagpie's (MMAG's) FY23 results demonstrated a resilient H2 performance, including a record Black Friday period. Multiple management initiatives, including a strategy to aid lower buying prices... ► Artikel lesen | ||
| 14.03. | Foresight Solar Fund - Optimising capital allocation | 273 | Foresight Solar Fund (FSFL) celebrated its 10-year anniversary of listing on the London Stock Exchange with decade-high cash distributions from assets of £120.4m in its FY23 results (year end 31 December).... ► Artikel lesen | ||
| 14.03. | BlackRock Latin American Investment Trust - Worthy allocation as part of a global portfolio | 166 | BlackRock Latin American Investment Trust's (BRLA's) lead manager Sam Vecht and deputy manager Christoph Brinkmann remain optimistic about the prospects for the region. Interest rates are coming down... ► Artikel lesen | ||
| 13.03. | Zalaris - Simplifying HR and payroll solutions | 217 | Zalaris is a leading European provider of comprehensive payroll and HR solutions and services, covering the entire employee lifecycle. The company's proprietary platform PeopleHub is tailored towards... ► Artikel lesen | ||
| 13.03. | Centaur Media - MAP23 plan delivers a higher-quality business | 209 | Centaur's FY23 results mark the end of its MAP23 margin acceleration plan, with the adjusted EBITDA margin more than doubling over its three-year course to 26%, ahead of the original 23% target. This... ► Artikel lesen | ||
| 13.03. | 4imprint Group - Continued market share gains | 248 | 4imprint's FY23 results are as outlined in January's trading update, with 16% top-line growth and a further step up in operating margin to 10.3% from 9.0%. Given that the trading backdrop became more... ► Artikel lesen | ||
| 13.03. | Mendus - Stars align for CADENCE combination trial | 225 | Mendus is forging ahead with vididencel, its primary clinical asset, aiming to address a market niche: the acute myeloid leukaemia (AML) maintenance setting. The company is gearing up to launch the... ► Artikel lesen | ||
| 12.03. | Nanoco - Mechanisms for shareholder returns confirmed | 240 | Following receipt of the £58.8m second tranche from the Samsung litigation on 24 January, Nanoco plans to return £30m to shareholders via a tender offer (c 38.5% of outstanding shares), alongside a... ► Artikel lesen | ||
| 12.03. | Nichols - Juicy profits and cash generation | 260 | Nichols' FY23 results showed good progress made as the Packaged business continued to drive growth through product innovation and geographic expansion. Inflationary pressures were largely mitigated... ► Artikel lesen | ||
| 12.03. | Inchcape - Acceleration in FY23 but more cautious FY24 | 109 | Inchcape's (INCH's) FY23 results highlighted strong revenue and margin progression, with 12% organic revenue growth and a 70bp uptick in adjusted operating margin, leading to 18% EPS growth. The Derco... ► Artikel lesen | ||
| 11.03. | Basilea Pharmaceutica - Strong Cresemba traction triggers milestone payment | 292 | Continued strong sales of Cresemba, Basilea Pharmaceutica's lead antifungal asset, in the Asia-Pacific region and China, has triggered the receipt of a US$1.25m milestone payment from Pfizer (license... ► Artikel lesen | ||
| 11.03. | Wheaton Precious Metals - Putting WPM onto GMT | 272 | On 20 February, Wheaton Precious Metals (WPM) announced that it had produced 14,615oz (15.2%) and sold 18,618oz (19.3%) more gold than our prior expectations for Q423, and produced 326koz (7.8%) and... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
